Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein lateral stalk subunit P0 pseudogene 1 (RPLP0P1, dJ777L9.2) is a processed pseudogene in the human genome, derived from the protein-coding gene RPLP0, which encodes a component of the 60S ribosomal subunit. RPLP0P1 itself does not produce a functional protein. Pseudogenes such as RPLP0P1 can occasionally participate in regulatory networks, for example by acting as decoys for microRNAs or influencing gene expression of their parent genes, but their function is often limited and context-dependent. There is no evidence that RPLP0P1 on its own is a molecular or therapeutic target, nor is it directly associated with disease or drug interaction[2][4]. This entry should not be used as a canonical drug target due to its pseudogene status and absence of any protein product or direct biological activity relevant to therapeutic intervention, biomarkers, or drug interactions[2][4][5].
Not applicable (not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P0 pseudogene 1 (RPLP0P1).